Luan Kim Bui

Array ( [id] => 3661874 [patent_doc_number] => 05656631 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-12 [patent_title] => 'Pyridazine derivatives' [patent_app_type] => 1 [patent_app_number] => 8/473580 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13774 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/656/05656631.pdf [firstpage_image] =>[orig_patent_app_number] => 473580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3815610 [patent_doc_number] => 05710271 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-20 [patent_title] => 'Process for the preparation and separation of diastereomeric salts of folinic acid' [patent_app_type] => 1 [patent_app_number] => 8/480097 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3261 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 361 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/710/05710271.pdf [firstpage_image] =>[orig_patent_app_number] => 480097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3660823 [patent_doc_number] => 05591861 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-07 [patent_title] => 'Optically active .omega.-halo-2-amino-alkanecarboxylic acid derivatives, process for the preparation thereof and their use for the preparation of optically active phosphorus-containing .alpha.-amino acids' [patent_app_type] => 1 [patent_app_number] => 8/466877 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6640 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 428 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/591/05591861.pdf [firstpage_image] =>[orig_patent_app_number] => 466877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3692197 [patent_doc_number] => 05604237 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-18 [patent_title] => 'Acridine derivatives' [patent_app_type] => 1 [patent_app_number] => 8/468620 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38320 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/604/05604237.pdf [firstpage_image] =>[orig_patent_app_number] => 468620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3571401 [patent_doc_number] => 05538958 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-23 [patent_title] => 'NMDA antagonists' [patent_app_type] => 1 [patent_app_number] => 8/468098 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11946 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/538/05538958.pdf [firstpage_image] =>[orig_patent_app_number] => 468098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3719126 [patent_doc_number] => 05616789 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-01 [patent_title] => 'Hydrazinecarboxylic acids' [patent_app_type] => 1 [patent_app_number] => 8/471595 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20822 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/616/05616789.pdf [firstpage_image] =>[orig_patent_app_number] => 471595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3625976 [patent_doc_number] => 05608066 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-04 [patent_title] => 'Methods for purifying camptothecin compounds' [patent_app_type] => 1 [patent_app_number] => 8/471772 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 5964 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/608/05608066.pdf [firstpage_image] =>[orig_patent_app_number] => 471772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3648912 [patent_doc_number] => 05637725 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'Substituted aryl and cycloalkyl imidazolones; a new class of GABA brain receptor ligands' [patent_app_type] => 1 [patent_app_number] => 8/462674 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7504 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637725.pdf [firstpage_image] =>[orig_patent_app_number] => 462674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3648887 [patent_doc_number] => 05637724 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'Substituted aryl and cycloalkyl imidazolones; a new class of GABA brain receptor ligands' [patent_app_type] => 1 [patent_app_number] => 8/461641 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7501 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637724.pdf [firstpage_image] =>[orig_patent_app_number] => 461641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3848748 [patent_doc_number] => 05719158 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-17 [patent_title] => '16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/463544 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25071 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/719/05719158.pdf [firstpage_image] =>[orig_patent_app_number] => 463544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3659834 [patent_doc_number] => 05659037 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Process for preparing chiral tetracyclic dopaminergic compounds' [patent_app_type] => 1 [patent_app_number] => 8/463326 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8227 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 452 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/659/05659037.pdf [firstpage_image] =>[orig_patent_app_number] => 463326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3683046 [patent_doc_number] => 05633273 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => '6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd] indoles' [patent_app_type] => 1 [patent_app_number] => 8/460323 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16582 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 315 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/633/05633273.pdf [firstpage_image] =>[orig_patent_app_number] => 460323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3666797 [patent_doc_number] => 05599819 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-04 [patent_title] => 'Acetylenes disubstituted with a thienyl or furyl group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4 - tetrahydroquinolinyl group having retinoid-like activity' [patent_app_type] => 1 [patent_app_number] => 8/458389 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13256 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 251 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/599/05599819.pdf [firstpage_image] =>[orig_patent_app_number] => 458389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3688818 [patent_doc_number] => 05643934 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => '6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz [CD]indoles' [patent_app_type] => 1 [patent_app_number] => 8/459563 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16572 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 336 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643934.pdf [firstpage_image] =>[orig_patent_app_number] => 459563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3732642 [patent_doc_number] => 05665744 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-09 [patent_title] => '6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenzn [cd] indoles' [patent_app_type] => 1 [patent_app_number] => 8/459431 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16299 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 337 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/665/05665744.pdf [firstpage_image] =>[orig_patent_app_number] => 459431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3716133 [patent_doc_number] => 05616597 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-01 [patent_title] => 'Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4--tetrahydroquinolinyl group having retinoid-like activity' [patent_app_type] => 1 [patent_app_number] => 8/460477 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13249 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 238 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/616/05616597.pdf [firstpage_image] =>[orig_patent_app_number] => 460477 [rel_patent_id] =>[rel_patent_doc_number] =>)